Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Two decisions by the British Appeal Court raise questions about the allowable breadth of biotechnology patents, but point to the charges patent-holders should be free to make.
Burundi and Rwanda have been hit before by atrocious cases of ethnic violence. Why are there discrepancies between these occurrences and the United Nations population data?
Recent advances in understanding of the eukaryotic cell cycle and its disruption in cancer have been dramatic. Participants at Nature's conference "Cycling out of control" (Paris, 1–2 December) found that they continue.
Three groups have together uncovered more than 20 distinct mutations in families with hereditary breast and ovarian cancer, offering important clues about the function of BRCA1.
On the market in the area of cell biology - a kit for CDS cell enrichment, an automated cell viability assay system and cultureware that provides anchorage-dependent cells with a suface that supports receptor-mediated cell adhesion.
